SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-006087
Filing Date
2019-02-06
Accepted
2019-02-06 16:13:40
Documents
9
Period of Report
2019-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-3947_48k.htm 8-K 34731
2 EX-1.1 a19-3947_4ex1d1.htm EX-1.1 236766
3 EX-4.1 a19-3947_4ex4d1.htm EX-4.1 138500
4 EX-5.1 a19-3947_4ex5d1.htm EX-5.1 22610
5 EX-99.1 a19-3947_4ex99d1.htm EX-99.1 11622
6 GRAPHIC g39474kmi001.gif GRAPHIC 1788
7 GRAPHIC g39474kmi002.gif GRAPHIC 4417
8 GRAPHIC g39474kk01i001.jpg GRAPHIC 1957
9 GRAPHIC g39474mmi001.jpg GRAPHIC 2667
  Complete submission text file 0001104659-19-006087.txt   460936
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 19571706
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1